Ensign Peak Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$201K Buy
2024
Q1
Sell
2023
Q4
$1.94M Hold
2023
Q3
$1.37M Hold
2023
Q2
$2.12M Hold
2023
Q1
$2.27M Hold
2022
Q4
$2.61M Sell
2022
Q3
$1.96M Buy
2022
Q2
$248K Hold
2022
Q1
$396K Buy